THEY SAID IT! U.S. SENATORS URGE FDA TO FURTHER CRACK DOWN ON BIG PHARMA’S DTC ADVERTISING
Apr 13, 2026
Bipartisan Letter Targets Big Pharma’s Misleading Ads That Inflate Costs And… Read More
© 2026 CSRXP- All Rights Reserved
Updates
THEY SAID IT! HHS OFFICIAL: “COMPETITION IS AN INCREDIBLY EFFECTIVE TOOL TO ADDRESS HIGH DRUG PRICES”
Mar 27, 2026
Administration Touts Positive Steps to Bring More Biosimilars to Market… Read More
DOSE OF REALITY: GSK’S BRAND NAME INHALER BAIT-AND-SWITCH INCREASED COSTS AND WORSENED HEALTH OUTCOMES
Mar 18, 2026
New Report Details Impact of Big Pharma Giant’s Strategy to Maintain… Read More
ICYMI: FDA GUIDANCE PROMOTES ACCELERATED BIOSIMILAR DEVELOPMENT AND COMPETITION
Mar 11, 2026
Boosting Biosimilar Competition and Cracking Down on Big Pharma’s Egregious… Read More
DOSE OF REALITY: HEALTH AFFAIRS SCHOLAR ANALYSIS FINDS BIG PHARMA’S PATENT ABUSE GROWING IN SCALE, KEEPING PRESCRIPTION DRUG PRICES HIGH
Mar 3, 2026
New Report Demonstrates How Brand Name Drug Companies Wield Litigation Around… Read More
CSRxP STATEMENT ON PRESIDENT TRUMP’S STATE OF THE UNION ADDRESS
Feb 24, 2026
Administration and Congress Must Enact Market-Based Solutions to Hold Big… Read More
BIG PHARMA EARNINGS WATCH: AMGEN AND BRISTOL MYERS SQUIBB
Feb 13, 2026
Big Pharma Tops Earnings Forecasts After Hiking Drug Prices, Again This month,… Read More
THEY SAID IT! LAWMAKERS AND EXPERTS CALL OUT BIG PHARMA’S ANTI-COMPETITIVE PLAYBOOK, URGE CONGRESS TO BOOST GENERIC AND BIOSIMILAR COMPETITION
Feb 12, 2026
U.S. House Energy & Commerce Health Subcommittee Hearing Puts Big Pharma… Read More
CSRxP: BIG PHARMA IS DRIVING HEALTH CARE INFLATION; CONGRESS MUST HOLD BIG PHARMA ACCOUNTABLE TO DELIVER AFFORDABILITY FOR AMERICAN PEOPLE
Feb 10, 2026
Campaign Encourages E&C Lawmakers to Focus on Big Pharma’s… Read More
DOSE OF REALITY: LAWMAKERS HAVE OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS PRICING AND ANTI-COMPETITIVE PRACTICES DRIVING HEALTH CARE COSTS
Feb 10, 2026
Big Pharma Sets Out-of-Control Launch Prices, Hikes Prices Outpacing… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, NOVARTIS, GSK AND ELI LILLY
Feb 9, 2026
Big Pharma Companies Beat Wall Street Earnings Expectations Amid Bonanza of… Read More
CSRxP Statement on the Launch of TrumpRx
Feb 6, 2026
Campaign Appreciates Administration’s Commitment to Lowering Drug Prices,… Read More